David Holsinger
Family Medicine · Johnstown, PANPI 1760412712
Payments from drug & device makers
Across 81 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- Lilly USA, LLC$135
- GSK$118
- Lundbeck LLC$61
- Abbott$58
- Astellas Pharma US Inc$45
- plus $330 from 14 others
What the payments were for
- Food & beverage$1,185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $438 |
| Lilly USA, LLC | 8 | $135 |
| GSK | 7 | $118 |
| Lundbeck LLC | 4 | $61 |
| Abbott | 3 | $58 |
| Astellas Pharma US Inc | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Amgen | 2 | $38 |
| Exact Sciences | 2 | $37 |
| Dexcom, Inc. | 2 | $34 |
| Merck | 2 | $28 |
| AstraZeneca | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Gilead | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Pfizer | 1 | $16 |
| Novo Nordisk | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Novartis | 1 | $12 |
How this compares
$1,185 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $40,054 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $37,017 |
| FarxigaDapagliflozin Propanediol | 33 | $18,426 |
| OzempicSemaglutide | 17 | $17,179 |
| JardianceEmpagliflozin | 22 | $15,599 |
| RybelsusSemaglutide | 13 | $12,532 |
| TrintellixVortioxetine Hydrobromide | 21 | $11,569 |
| Atrovent HfaIpratropium Bromide | 15 | $7,340 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $4,765 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 101 | $2,667 |
| Atorvastatin Calcium | 241 | $2,436 |
| Potassium Chloride | 63 | $1,755 |
| Febuxostat | 11 | $1,503 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,167 |
| Pantoprazole Sodium | 133 | $1,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $40,05454 claims |
| GSKTrelegy Ellipta | $118 | $37,01755 claims |
| Novo NordiskOzempic, Rybelsus | $13 | $29,71230 claims |
| AstraZenecaFarxiga | $23 | $18,42633 claims |
| AbbVieSynthroid | $438 | $61116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Johnstown
- Richard KastelicJohnstown$700K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.